A vial of research-grade peptide might read "10 mg," but a label is a claim, not a measurement. Confirming how much of a specific peptide is actually in solution — and whether it's the right sequence at all — is an analytical problem, and one of the oldest and most trusted answers is the ELISA. What follows is a research use only explainer of how the enzyme-linked immunosorbent assay measures peptides in vitro: what it is, the formats labs choose between, how a colour change becomes a concentration, and why short peptides give analysts more trouble than proteins.
Quantification is the quiet backbone of peptide characterization. A concentration or purity figure on a certificate of analysis usually traces back, somewhere upstream, to an immunoassay reading an antibody-binding event. Learn how ELISA works and you learn what those numbers mean — and what they don't.
What ELISA Actually Is
In one line: ELISA turns "is my target here, and how much?" into a colour you can measure. It's an immunoassay — it works because an antibody recognises a specific molecular shape — coupled to an enzyme that generates a visible signal.
The mechanics are straightforward. The target, or antigen, is immobilised on a solid surface, typically the wells of a 96- or 384-well polystyrene plate. An antibody that recognises the target carries an attached enzyme; add a matching substrate and that enzyme converts it into a coloured product. Because the reagents are anchored to the plate, unbound material washes away, leaving signal only where the target was captured. The amount of colour tracks the amount of target — that's the whole idea, and it's why the assay is a workhorse for detecting and measuring peptides, proteins, antibodies, and hormones (StatPearls, NCBI Bookshelf).
Picture it this way. The antibody is a lock that fits only one key, and the enzyme is a tiny colour factory switched on only at the locks where the key clicked into place. Count the colour, and you've counted the keys.
The four formats at a glance
ELISA isn't one method but a family of four, differing in how the target is captured and detected (StatPearls):
- Direct — an enzyme-linked primary antibody binds the plate-bound target. Fast and simple, but the least sensitive.
- Indirect — a primary antibody binds the target, then an enzyme-linked secondary antibody binds the primary. More sensitive and more flexible, at the cost of possible secondary-antibody cross-reactivity.
- Sandwich — the target is caught between a capture antibody on the plate and a detection antibody in solution. The most sensitive format, and the signal rises with concentration.
- Competitive — the target competes with a labelled reference for a limited amount of antibody. Here the signal falls as concentration rises, which makes it the go-to for small targets.
Detecting a Peptide: Capture and Signal
This section answers a practical question: how does a lab get a specific peptide to stick to a plate and light up? Two halves — immobilisation and signal generation.
Immobilising the target
For peptide work, the antigen is often the peptide itself, and the sequence is chosen deliberately. In one representative study, researchers used B-cell epitope prediction (via the Immune Epitope Database) to pick linear, accessible stretches of a protein, then synthesised those short peptides as the coating antigen. The peptide went onto the plate in a carbonate-bicarbonate buffer at pH 9.6, left overnight at 4 °C so it would bind the polystyrene (peptide-based ELISA, PMC).
Getting the concentrations right is its own exercise. A "checkerboard" titration systematically varies the coating concentration, the sample dilution, and the enzyme-conjugate dilution to find the combination that gives the cleanest split between positive and negative signal. In that study, optimisation landed on a specific coating concentration and conjugate dilution for each peptide — small differences that reflected how accessible each epitope was (PMC).